Aperio Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$417K Buy
21,088
+770
+4% +$15.2K ﹤0.01% 2044
2020
Q3
$265K Sell
20,318
-4,658
-19% -$60.8K ﹤0.01% 2120
2020
Q2
$283K Buy
24,976
+853
+4% +$9.67K ﹤0.01% 2052
2020
Q1
$345K Buy
24,123
+6,962
+41% +$99.6K ﹤0.01% 1833
2019
Q4
$467K Sell
17,161
-4,019
-19% -$109K ﹤0.01% 1845
2019
Q3
$606K Sell
21,180
-635
-3% -$18.2K ﹤0.01% 1649
2019
Q2
$606K Sell
21,815
-3,790
-15% -$105K ﹤0.01% 1666
2019
Q1
$850K Buy
25,605
+2,276
+10% +$75.6K ﹤0.01% 1441
2018
Q4
$678K Buy
23,329
+5,854
+33% +$170K ﹤0.01% 1513
2018
Q3
$804K Buy
17,475
+1,648
+10% +$75.8K ﹤0.01% 1529
2018
Q2
$591K Buy
15,827
+924
+6% +$34.5K ﹤0.01% 1664
2018
Q1
$440K Buy
14,903
+662
+5% +$19.5K ﹤0.01% 1753
2017
Q4
$489K Buy
14,241
+2,509
+21% +$86.2K ﹤0.01% 1714
2017
Q3
$424K Sell
11,732
-397
-3% -$14.3K ﹤0.01% 1738
2017
Q2
$313K Buy
12,129
+534
+5% +$13.8K ﹤0.01% 1871
2017
Q1
$223K Buy
+11,595
New +$223K ﹤0.01% 1986
2016
Q3
Sell
-11,577
Closed -$354K 2076
2016
Q2
$354K Sell
11,577
-1,481
-11% -$45.3K ﹤0.01% 1584
2016
Q1
$489K Buy
13,058
+1,805
+16% +$67.6K ﹤0.01% 1381
2015
Q4
$486K Buy
11,253
+323
+3% +$14K ﹤0.01% 1348
2015
Q3
$410K Buy
10,930
+651
+6% +$24.4K ﹤0.01% 1416
2015
Q2
$349K Buy
10,279
+1,084
+12% +$36.8K ﹤0.01% 1538
2015
Q1
$326K Buy
9,195
+1,250
+16% +$44.3K ﹤0.01% 1519
2014
Q4
$271K Sell
7,945
-1,183
-13% -$40.4K ﹤0.01% 1574
2014
Q3
$352K Buy
9,128
+676
+8% +$26.1K ﹤0.01% 1308
2014
Q2
$329K Sell
8,452
-66
-0.8% -$2.57K ﹤0.01% 1345
2014
Q1
$291K Buy
+8,518
New +$291K ﹤0.01% 1643
2013
Q3
Sell
-7,684
Closed -$206K 1809
2013
Q2
$206K Buy
+7,684
New +$206K ﹤0.01% 1487